1

Biolife Solutions

#6094

Rank

$942.33M

Marketcap

US United States

Country

Biolife Solutions
Leadership team

Mr. Michael P. Rice (Chairman & CEO)

Mr. Roderick de Greef (Pres & COO)

Mr. Troy Wichterman (Chief Financial Officer)

Products/ Services
Biotechnology, Commercial, Industrial, Medical
Number of Employees
100 - 500
Headquarters
Bothell, Washington, United States
Established
1987
Company Registration
SEC CIK number: 0000834365
Revenue
100M - 500M
Traded as
BLFS
Social Media
Overview
Location
Summary
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
History

Biolife Solutions was founded in 2012 to address the challenges associated with cryopreservation, cold storage and preservation for cell therapy, tissue engineering and regenerative medicine. The company’s executive team has decades of experience developing, validating and manufacturing cell therapy, tissue engineering and regenerative medicine products. The company’s initial product offering focused on cryopreservation and cold storage solutions for cryopreservation systems, cryobanks and cell therapy manufacturers.

Mission
Biolife Solutions’ mission is to develop and commercialize innovative, best-in-class products and technologies that advance the state of biopreservation and biobanking.
Vision
We are dedicated to evolving biopreservation and biobanking to drive breakthroughs in cell therapy, tissue engineering and regenerative medicine.
Key Team

Dr. Aby J. Mathew (Chairman of Scientific Advisory Board, Exec. VP & Chief Scientific Officer)

Mr. Marcus Schulz (Chief Revenue Officer)

Mr. Todd Berard (Chief Marketing Officer)

Ms. Sarah Aebersold J.D. (VP of Global HR)

Ms. Karen Foster (Chief Quality Officer)

Recognition and Awards
Biolife Solutions has been recognized for its innovative approaches to biopreservation and biobanking. The company has received awards from The Scientist, Inc. Magazine and the Cell & Gene Therapy Catapult.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Biolife Solutions
Leadership team

Mr. Michael P. Rice (Chairman & CEO)

Mr. Roderick de Greef (Pres & COO)

Mr. Troy Wichterman (Chief Financial Officer)

Products/ Services
Biotechnology, Commercial, Industrial, Medical
Number of Employees
100 - 500
Headquarters
Bothell, Washington, United States
Established
1987
Company Registration
SEC CIK number: 0000834365
Revenue
100M - 500M
Traded as
BLFS
Social Media